688139 海尔生物
已收盘 09-07 15:00:00
资讯
新帖
简况
每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万
证券之星 · 09-06 02:22
每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 09-03
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%
证券之星 · 09-01
海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%
【机构调研记录】红土创新基金调研胜宏科技、海尔生物
证券之星 · 08-31
【机构调研记录】红土创新基金调研胜宏科技、海尔生物
股市必读:海尔生物(688139)8月25日董秘有最新回复
证券之星 · 08-26
股市必读:海尔生物(688139)8月25日董秘有最新回复
海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展
证券之星 · 08-25
海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展
股市必读:海尔生物(688139)8月24日董秘有最新回复
证券之星 · 08-25
股市必读:海尔生物(688139)8月24日董秘有最新回复
海尔生物:截至2026年8月20日,公司股东总数为14,780户
证券之星 · 08-24
海尔生物:截至2026年8月20日,公司股东总数为14,780户
股市必读:海尔生物新发布《海尔生物2026年度“提质增效重回报”2.0行动方案》
证券之星 · 08-24
股市必读:海尔生物新发布《海尔生物2026年度“提质增效重回报”2.0行动方案》
每周股票复盘:海尔生物(688139)股东户数增2.01%
证券之星 · 08-23
每周股票复盘:海尔生物(688139)股东户数增2.01%
拐点之后,海尔生物新一轮增长从哪里来?
证券之星 · 08-21
拐点之后,海尔生物新一轮增长从哪里来?
股市必读:海尔生物新发布《海尔生物2026年半年度报告摘要》
证券之星 · 08-21
股市必读:海尔生物新发布《海尔生物2026年半年度报告摘要》
海尔生物(688139)披露2026年半年度报告,8月19日股价下跌2.21%
证券之星 · 08-19
海尔生物(688139)披露2026年半年度报告,8月19日股价下跌2.21%
每周股票复盘:海尔生物(688139)股东户数增2.01%,持股市值63.21万
证券之星 · 08-16
每周股票复盘:海尔生物(688139)股东户数增2.01%,持股市值63.21万
股市必读:海尔生物新发布《海尔生物关于召开2026年半年度业绩说明会的公告》
证券之星 · 08-14
股市必读:海尔生物新发布《海尔生物关于召开2026年半年度业绩说明会的公告》
海尔生物(688139)披露2026年半年度业绩说明会公告,8月12日股价下跌0.55%
证券之星 · 08-12
海尔生物(688139)披露2026年半年度业绩说明会公告,8月12日股价下跌0.55%
海尔生物:截至2026年8月10日,公司股东总数为14,595户
证券之星 · 08-12
海尔生物:截至2026年8月10日,公司股东总数为14,595户
每周股票复盘:海尔生物(688139)股东户数减少至1.43万户
证券之星 · 08-09
每周股票复盘:海尔生物(688139)股东户数减少至1.43万户
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 08-05
股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》
海尔生物:研发了航天专用冰箱
证券之星 · 08-04
海尔生物:研发了航天专用冰箱
加载更多
公司概况
公司名称:
青岛海尔生物医疗股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-10-25
主营业务:
青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。
发行价格:
15.53
{"stockData":{"symbol":"688139","market":"SH","secType":"STK","nameCN":"海尔生物","latestPrice":31.5,"timestamp":1788764400000,"preClose":30.8,"halted":0,"volume":4208299,"delay":0,"changeRate":0.0227,"floatShares":316000000,"shares":316000000,"eps":0.807,"marketStatus":"已收盘","change":0.7,"latestTime":"09-07 15:00:00","open":30.8,"high":31.93,"low":30.65,"amount":133000000,"amplitude":0.0416,"askPrice":31.56,"askSize":1,"bidPrice":31.5,"bidSize":30,"shortable":0,"etf":0,"ttmEps":0.807,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788831000000},"marketStatusCode":5,"adr":0,"adjPreClose":30.8,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788744600000,1788751800000],[1788757200000,1788764400000]],"highLimit":33.88,"lowLimit":27.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":316492922,"isCdr":false,"pbRate":2.25,"roa":"--","peRate":39.033457,"roe":"3.34%","epsLYR":0.8,"committee":-0.301115,"marketValue":9970000000,"turnoverRate":0.0133,"status":0,"afterMarket":{"amount":0,"volume":0,"close":31.5,"buyVolume":0,"sellVolume":0,"time":1788766437746,"indexStatus":"已收盘 09-07 15:30:00","preClose":30.8},"floatMarketCap":9970000000},"requestUrl":"/m/hq/s/688139","defaultTab":"news","newsList":[{"id":"2665652623","title":"每周股票复盘:海尔生物(688139)已回购697,661股耗资超2082万","url":"https://stock-news.laohu8.com/highlight/detail?id=2665652623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665652623?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:22","pubTimestamp":1788632532,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,海尔生物报收于30.8元,较上周的31.64元下跌2.65%。本周,海尔生物9月1日盘中最高价报31.67元。本周关注点公司公告汇总:海尔生物已累计回购697,661股,支付资金总额超2082万元。公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664469118","title":"股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664469118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664469118?lang=zh_cn&edition=full","pubTime":"2026-09-03 03:13","pubTimestamp":1788376390,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,海尔生物报收于31.05元,下跌1.33%,换手率0.85%,成交量2.68万手,成交额8372.18万元。公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。本次回购符合相关法规及公司方案规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664048857","title":"海尔生物(688139)披露以集中竞价交易方式回购公司股份的进展公告,9月1日股价上涨0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664048857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664048857?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:59","pubTimestamp":1788274750,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,海尔生物报收于31.47元,较前一交易日上涨0.9%,最新总市值为99.6亿元。该股当日开盘31.19元,最高31.67元,最低31.0元,成交额达1.3亿元,换手率为1.31%。近日,海尔生物发布《关于以集中竞价交易方式回购公司股份的进展公告》。公告显示,公司于2026年7月20日至2027年7月19日实施股份回购,拟回购金额为5,000万元至1亿元,用于减少注册资本。本次回购符合相关法规及公司方案规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663939028","title":"【机构调研记录】红土创新基金调研胜宏科技、海尔生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2663939028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663939028?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:03","pubTimestamp":1788134636,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及8月28日披露的机构调研信息,红土创新基金近期对2家上市公司进行了调研,相关名单如下:1)胜宏科技 调研纪要:公司2026年固定资产投资不超过180亿元,主要用于国内扩产。Q2毛利率承压因人员扩张与折旧增加,后续营收增长将带动毛利率回升。旗下最近一年表现最佳的公募基金产品为红土创新新兴产业混合A,最新单位净值为4.41,近一年增长94.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SGXZ49509284.SGD","LU0164880469.USD","SGXZ81163826.USD","LU0531971595.HKD","LU1808992512.USD","LU0469268626.HKD","LU1481107354.HKD","LU0149721374.USD","LU1979443071.USD","BK0251","LU2488822045.USD","02476","LU0039217434.USD","BK0197","LU0164865239.USD","LU0871576103.HKD","BK1170","688139","LU1934453819.USD","300476","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768620","title":"股市必读:海尔生物(688139)8月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662768620?lang=zh_cn&edition=full","pubTime":"2026-08-26 07:06","pubTimestamp":1787699181,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,海尔生物报收于30.01元,上涨3.48%,换手率1.34%,成交量4.23万手,成交额1.26亿元。截至2026年上半年,公司并购子公司的资本回报率整体达双位数,并购业务收入复合增长率达30%,对整体收入贡献已超30%。后续若有实质进展,公司将依法依规履行信披义务,请您留意公司相关公告。当日关注点交易信息汇总:8月25日主力资金净流入239.63万元,占总成交额1.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600012155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782190","title":"海尔生物:可支配资金约25亿元,力争年内取得并购实质性进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662782190?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:22","pubTimestamp":1787646162,"startTime":"0","endTime":"0","summary":"有投资者在互动平台向海尔生物提问,公司目前账面现金储备是否支持规模较大的外延式并购,以及资本开支方面的优先级如何。海尔生物回复称,截至2026年上半年,公司含货币资金、其他非流动资产在内的可支配资金合计约25亿元,占总资产比重超过40%,资产负债率长期维持在20%左右。目前主要围绕两条主线推进并购布局:一是生物制造核心装备和试剂耗材,二是通过技术外延支持新场景拓展,并力争年内取得实质性进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082500032931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662145205","title":"股市必读:海尔生物(688139)8月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2662145205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662145205?lang=zh_cn&edition=full","pubTime":"2026-08-25 03:39","pubTimestamp":1787600372,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,海尔生物报收于29.0元,下跌1.83%,换手率1.39%,成交量4.4万手,成交额1.28亿元。董秘最新回复投资者: 您好!请问截至8月20日收盘公司股东人数是多少,谢谢!董秘: 尊敬的投资者您好,截至2026年8月20日,公司股东总数为14,780户。当日关注点交易信息汇总:8月24日主力资金净流入69.1万元,占总成交额0.54%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500008011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222740","title":"海尔生物:截至2026年8月20日,公司股东总数为14,780户","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661222740?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:54","pubTimestamp":1787565258,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)08月24日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至8月20日收盘公司股东人数是多少,谢谢!海尔生物回复:尊敬的投资者您好,截至2026年8月20日,公司股东总数为14,780户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400025146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661498482","title":"股市必读:海尔生物新发布《海尔生物2026年度“提质增效重回报”2.0行动方案》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661498482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661498482?lang=zh_cn&edition=full","pubTime":"2026-08-24 06:37","pubTimestamp":1787524629,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,海尔生物报收于29.54元,下跌1.66%,换手率1.55%,成交量4.9万手,成交额1.45亿元。公司公告汇总:海尔生物发布2026年度“提质增效重回报”2.0行动方案,明确海外收入、并购收入及AI相关业务收入占比目标分别为不低于50%、40%、30%。公司已连续七年分红,2025年分红比例达41.03%,并推出第四轮回购计划;同步加强投资者沟通,披露ESG报告,提升治理水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400002221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661021476","title":"每周股票复盘:海尔生物(688139)股东户数增2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661021476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661021476?lang=zh_cn&edition=full","pubTime":"2026-08-23 04:59","pubTimestamp":1787432347,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,海尔生物报收于29.54元,较上周的28.84元上涨2.43%。股本股东变化截至2026年8月10日,公司股东户数为1.46万户,较7月31日增加287户,增幅2.01%。公司公告汇总青岛海尔生物医疗股份有限公司2026年半年度报告摘要显示,报告期末总资产为5,826,713,180.16元,较上年度末增长0.61%;归属于上市公司股东的净资产为4,421,421,549.27元,较上年度末增长1.04%。青岛海尔生物医疗股份有限公司披露2026年半年度募集资金存放、管理与实际使用情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300001262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217257","title":"拐点之后,海尔生物新一轮增长从哪里来?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661217257?lang=zh_cn&edition=full","pubTime":"2026-08-21 14:41","pubTimestamp":1787294518,"startTime":"0","endTime":"0","summary":"8月20日,2026年半年报披露后,海尔生物举行投资者交流会。二季度进一步提速,收入同比增长27%,归母净利润同比增长109%。拐点之后,海尔生物需要证明的已经不只是“恢复”,而是能不能建立一套新的增长结构。进入2026年,海外、新兴产业和制药被进一步明确为重点增长方向。上半年,海尔生物制药终端增长23%,对公司整体收入增幅贡献约3个百分点。未来三条曲线,增长路径清晰明确如果把时间拉到未来五年,海尔生物给出的路径更加清楚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026082100021849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236057","title":"股市必读:海尔生物新发布《海尔生物2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661236057?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:09","pubTimestamp":1787245751,"startTime":"0","endTime":"0","summary":"公司公告汇总海尔生物2026年半年度报告摘要报告期末总资产为5,826,713,180.16元,较上年度末增长0.61%;归属于上市公司股东的净资产为4,421,421,549.27元,较上年度末增长1.04%。海尔生物2026年半年度募集资金存放、管理与实际使用情况的专项报告2019年首次公开发行募集资金净额11.57亿元,截至2026年6月30日累计使用11.70亿元,期末余额20,959.33元。2026年上半年营业收入增速达8.45%,归母净利润实现正增长,扣非归母净利润同比增长11.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429439","title":"海尔生物(688139)披露2026年半年度报告,8月19日股价下跌2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429439","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429439?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:25","pubTimestamp":1787149513,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘,海尔生物报收于28.33元,较前一交易日下跌2.21%,最新总市值为89.66亿元。该股当日开盘28.96元,最高29.15元,最低28.0元,成交额达8402.71万元,换手率为0.93%。近日,海尔生物发布2026年半年度报告。本报告期实现营业收入1,296,472,460.72元,同比增长8.45%;利润总额为156,464,435.86元,同比增长0.17%;归属于上市公司股东的净利润为147,414,556.88元,同比增长3.28%;归属于上市公司股东的扣除非经常性损益的净利润为137,547,657.29元,同比增长11.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900043280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659644176","title":"每周股票复盘:海尔生物(688139)股东户数增2.01%,持股市值63.21万","url":"https://stock-news.laohu8.com/highlight/detail?id=2659644176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659644176?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:08","pubTimestamp":1786820894,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,海尔生物报收于28.84元,较上周的29.14元下跌1.03%。本周,海尔生物8月10日盘中最高价报29.83元。本周关注点股本股东变化:股东户数较前期增加2.01%,户均持股市值为63.21万元公司公告汇总:公司将召开2026年半年度业绩说明会,高管将出席答疑股本股东变化截至2026年8月10日,公司股东户数为1.46万户,较7月31日增加287.0户,增幅2.01%。户均持股数量由上期的2.21万股降至2.17万股,户均持股市值为63.21万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","BK0251","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659416117","title":"股市必读:海尔生物新发布《海尔生物关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416117","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659416117?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:16","pubTimestamp":1786644974,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,海尔生物报收于29.1元,上涨1.04%,换手率1.21%,成交量3.82万手,成交额1.11亿元。公司公告汇总:海尔生物将于8月21日13:00–14:00召开2026年半年度业绩说明会,董事、CEO刘占杰等高管将出席,投资者可于8月14日至20日16:00前提交问题。公司董事、首席执行官刘占杰,独立董事许铭,首席财务官莫瑞娟,董事会秘书黄艳莉将出席。说明会后可通过该平台查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097320","title":"海尔生物(688139)披露2026年半年度业绩说明会公告,8月12日股价下跌0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658097320?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:33","pubTimestamp":1786527202,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,海尔生物报收于28.8元,较前一交易日下跌0.55%,最新总市值为91.15亿元。近日,海尔生物发布《关于召开2026年半年度业绩说明会的公告》。公告显示,青岛海尔生物医疗股份有限公司将于2026年08月21日13:00-14:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。投资者可于2026年08月14日至08月20日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688139","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658922421","title":"海尔生物:截至2026年8月10日,公司股东总数为14,595户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658922421","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658922421?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:33","pubTimestamp":1786520039,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:您好!请问截至8月10日公司股东人数是多少,谢谢海尔生物回复:尊敬的投资者您好,截至2026年8月10日,公司股东总数为14,595户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200021130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0251","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658675864","title":"每周股票复盘:海尔生物(688139)股东户数减少至1.43万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658675864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658675864?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:21","pubTimestamp":1786213270,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,海尔生物报收于29.14元,较上周的28.23元上涨3.22%。本周,海尔生物8月4日盘中最高价报29.28元。海尔生物当前最新总市值92.23亿元,在医疗器械板块市值排名33/129,在两市A股市值排名1954/5205。股本股东变化股东户数变动截至2026年7月31日,海尔生物股东户数为1.43万户,较7月20日减少4.0户,减幅0.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688139","LU2488822045.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563941","title":"股市必读:海尔生物新发布《海尔生物关于以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563941","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563941?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:57","pubTimestamp":1785866233,"startTime":"0","endTime":"0","summary":"公司公告汇总海尔生物关于以集中竞价交易方式回购公司股份的进展公告青岛海尔生物医疗股份有限公司于2026年7月20日至7月31日期间,通过集中竞价交易方式累计回购股份177,341股,占公司总股本的0.0560%,已支付资金总额为5,009,210.10元,回购价格区间为28.15元/股至28.33元/股。本次回购股份用于减少注册资本。在股份回购方面,公司已推出四轮回购计划,前三轮累计回购金额约2.5亿元,并于今年1月注销部分已回购股份145.96万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","LU2488822045.USD","688139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656367535","title":"海尔生物:研发了航天专用冰箱","url":"https://stock-news.laohu8.com/highlight/detail?id=2656367535","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656367535?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:45","pubTimestamp":1785833113,"startTime":"0","endTime":"0","summary":"证券之星消息,海尔生物(688139)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问:公司产品有用于轻舟试验飞船上吗,海尔生物回复:尊敬的投资者您好,凭借核心技术储备及研发能力,公司研发了航天专用冰箱,已搭载神舟系列飞船被送往外层空间执行空间科研任务,详情可参考《青岛海尔生物医疗股份有限公司首次公开发行股票并在科创板上市招股说明书》。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","688139","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788801321874,"stockEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":0.081},{"period":"3month","weight":0.1469},{"period":"6month","weight":0.0145},{"period":"1year","weight":-0.0202},{"period":"ytd","weight":0.0033}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0193},{"period":"6month","weight":-0.0486},{"period":"1year","weight":0.0315},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛海尔生物医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"14780人(较上一季度增加1.27%)","perCapita":"21413股","listingDate":"2019-10-25","address":"山东省青岛市城阳区高新区丰源路280号","registeredCapital":"31649万元","survey":" 青岛海尔生物医疗股份有限公司的主营业务是为生物医药企业、高校科研机构、医院、疾控等用户提供数字化场景解决方案。公司的主要产品是智慧平台、样本存储、药品、疫苗存储、血液存储。根据全球权威调研机构欧睿国际(Euromonitor)认证,公司已经成为“全球生命科学实验室设备中国自主品牌销售额第一”及“生命科学实验室设备中国自主品牌海外销售额第一”。","listedPrice":15.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海尔生物,688139,海尔生物股票,海尔生物股票老虎,海尔生物股票老虎国际,海尔生物行情,海尔生物股票行情,海尔生物股价,海尔生物股市,海尔生物股票价格,海尔生物股票交易,海尔生物股票购买,海尔生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海尔生物(688139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海尔生物(688139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}